
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. PACB
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. statistics & valuation
P / B95.8×
Net margin-341.5%
FCF margin-71.2%
Return on capital-77.9%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Net margin (%)Gross margin (%)Operating margin (%)Return on equity (%)Shares outstandingNet debt ($)Share buybacks ($)Return on assets (%)Free cash flow margin (%)Debt / equity (×)EPS ($) Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|
| Gross margin | 28.6% | 24.2% | 26.3% | 38.2% | 45.1% | 41.3% | 38.0% | 31.9% | 37.1% | 48.7% |
| Operating margin | -346.2% | -308.0% | -166.8% | -239.4% | -161.2% | -132.3% | -110.6% | -128.4% | -96.1% | -78.5% |
| Net margin | -341.5% | -201.2% | -153.0% | -244.9% | -138.9% | 37.3% | -92.6% | -130.4% | -98.6% | -82.0% |
| FCF margin | -71.2% | -137.8% | -133.7% | -218.2% | -89.7% | 23.4% | -89.3% | -86.8% | -83.4% | -83.9% |
| Return on assets | -69.7% | -24.6% | -17.6% | -17.8% | -9.0% | 7.1% | -56.9% | -60.2% | -64.0% | -53.9% |
| Return on equity | -10214.5% | -61.2% | -43.7% | -55.8% | -22.9% | 8.8% | -153.2% | -89.9% | -107.1% | -87.8% |
| Debt / equity | — | — | — | 1.59× | 1.13× | — | 0.29× | 0.13× | 0.16× | 0.19× |
| Current ratio | 5.15 | 7.48 | 7.81 | 3.24 | 15.36 | 9.24 | 1.65 | 4.90 | 3.55 | 3.23 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.